These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 29428473)
1. Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212). Ito M; Kobayashi A; Fujita S; Mizusawa J; Kanemitsu Y; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y; Eur J Surg Oncol; 2018 Apr; 44(4):463-468. PubMed ID: 29428473 [TBL] [Abstract][Full Text] [Related]
2. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y; Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948 [TBL] [Abstract][Full Text] [Related]
3. Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212. Saito S; Fujita S; Mizusawa J; Kanemitsu Y; Saito N; Kinugasa Y; Akazai Y; Ota M; Ohue M; Komori K; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y; Eur J Surg Oncol; 2016 Dec; 42(12):1851-1858. PubMed ID: 27519616 [TBL] [Abstract][Full Text] [Related]
4. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial. Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Murata K; Akagi Y; Takiguchi N; Saida Y; Nakamura K; Fukuda H; Akasu T; Moriya Y; Ann Surg; 2017 Aug; 266(2):201-207. PubMed ID: 28288057 [TBL] [Abstract][Full Text] [Related]
5. Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212). Komori K; Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Shiomi A; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Kinugasa Y; Takii Y; Akasu T; Moriya Y; Eur J Surg Oncol; 2019 Mar; 45(3):336-340. PubMed ID: 30477950 [TBL] [Abstract][Full Text] [Related]
6. Laparoscopic Versus Open Lateral Lymph Node Dissection for Locally Advanced Low Rectal Cancer: A Subgroup Analysis of a Large Multicenter Cohort Study in Japan. Yamaguchi T; Konishi T; Kinugasa Y; Yamamoto S; Akiyoshi T; Okamura R; Ito M; Nishimura Y; Shiozawa M; Yamaguchi S; Hida K; Sakai Y; Watanabe M Dis Colon Rectum; 2017 Sep; 60(9):954-964. PubMed ID: 28796734 [TBL] [Abstract][Full Text] [Related]
7. Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer. Akasu T; Sugihara K; Moriya Y Ann Surg Oncol; 2009 Oct; 16(10):2779-86. PubMed ID: 19626377 [TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212). Tsukamoto S; Fujita S; Ota M; Mizusawa J; Shida D; Kanemitsu Y; Ito M; Shiomi A; Komori K; Ohue M; Akazai Y; Shiozawa M; Yamaguchi T; Bando H; Tsuchida A; Okamura S; Akagi Y; Takiguchi N; Saida Y; Akasu T; Moriya Y; Br J Surg; 2020 Apr; 107(5):586-594. PubMed ID: 32162301 [TBL] [Abstract][Full Text] [Related]
9. A Phase II/III randomized controlled trial comparing perioperative versus postoperative chemotherapy with mFOLFOX6 for lower rectal cancer with suspected lateral pelvic node metastasis: Japan Clinical Oncology Group Study JCOG1310 (PRECIOUS study). Ohue M; Iwasa S; Kanemitsu Y; Hamaguchi T; Shiozawa M; Ito M; Yasui M; Katayama H; Mizusawa J; Shimada Y; Jpn J Clin Oncol; 2017 Jan; 47(1):84-87. PubMed ID: 27655905 [TBL] [Abstract][Full Text] [Related]
10. Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: A comparison of 2 high-volume centers in Japan that employ different policies concerning LLND. Kanemitsu Y; Komori K; Shida D; Ochiai H; Tsukamoto S; Kinoshita T; Moriya Y Surgery; 2017 Aug; 162(2):303-314. PubMed ID: 28366499 [TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of survival and functional outcomes after total mesorectal excision with or without lateral pelvic lymph node dissection in rectal cancer surgery. Hajibandeh S; Hajibandeh S; Matthews J; Palmer L; Maw A Surgery; 2020 Sep; 168(3):486-496. PubMed ID: 32620303 [TBL] [Abstract][Full Text] [Related]
12. Mesorectal excision with or without lateral lymph node dissection for elderly patients with mid-low rectal cancer: safety and feasibility analysis. Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q; Jpn J Clin Oncol; 2023 Jan; 53(1):26-34. PubMed ID: 36354102 [TBL] [Abstract][Full Text] [Related]
13. [Comparison on efficacy between fascia-oriented versus vascular-oriented lateral lymph node dissection in patients with rectal cancer]. Wang ZJ; Liu Z; Liang JW; Zhang MG; Mei SW; Shen HY; Chen JN; Li J; Zhao FQ; Wei FZ; Xiao TX; Liu Q Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jul; 24(7):611-618. PubMed ID: 34289546 [No Abstract] [Full Text] [Related]
14. Impact of autonomic nerve preservation and lateral node dissection on male urogenital function after total mesorectal excision for lower rectal cancer. Kyo K; Sameshima S; Takahashi M; Furugori T; Sawada T World J Surg; 2006 Jun; 30(6):1014-9. PubMed ID: 16736330 [TBL] [Abstract][Full Text] [Related]
16. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy. Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352 [TBL] [Abstract][Full Text] [Related]
17. Laparoscopic mesorectal excision with preservation of the pelvic autonomic nerves for rectal cancer. Fukunaga Y; Higashino M; Tanimura S; Kishida S; Fujiwara Y; Ogata A; Osugi H Hepatogastroenterology; 2007; 54(73):85-90. PubMed ID: 17419237 [TBL] [Abstract][Full Text] [Related]
18. Outcome of lateral pelvic lymph node dissection with total mesorectal excision in treatment of rectal cancer: A systematic review and meta-analysis. Emile SH; Elfeki H; Shalaby M; Sakr A; Kim NK Surgery; 2021 May; 169(5):1005-1015. PubMed ID: 33317903 [TBL] [Abstract][Full Text] [Related]
19. Oncological outcomes of robotic-assisted laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer. Yamaguchi T; Kinugasa Y; Shiomi A; Kagawa H; Yamakawa Y; Furutani A; Manabe S; Yamaoka Y; Hino H Surg Endosc; 2018 Nov; 32(11):4498-4505. PubMed ID: 29721748 [TBL] [Abstract][Full Text] [Related]
20. Application of indocyanine green-enhanced near-infrared fluorescence-guided imaging in laparoscopic lateral pelvic lymph node dissection for middle-low rectal cancer. Zhou SC; Tian YT; Wang XW; Zhao CD; Ma S; Jiang J; Li EN; Zhou HT; Liu Q; Liang JW; Zhou ZX; Wang XS World J Gastroenterol; 2019 Aug; 25(31):4502-4511. PubMed ID: 31496628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]